OFIX News and Press, Orthofix Medical Inc. From 12/01/23

Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire ...

NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim involving the board of directors of Orthofix Medical Inc. (“Orthofix” or the “...

With more than 100,000 implantations worldwide, the M6-C and M6-L discs continue to demonstrate strong clinical performance, safety and patient benefits Orthofix Medical Inc . (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of the five-...

2023-11-28 08:44:35 ET More on Enovis, Orthofix, Enovis Making Good Choices, But Not Seeing The Rewards Orthofix Non-GAAP EPS of $0.07 beats by $0.28, revenue of $184M misses by $1.79M Enovis Corporation Non-GAAP EPS of $0.56 beats by $0.02, revenue of $417.52M beats...

Value-Building Medical Device Executive with 20-Year Record of Driving Market-Leading Growth Across Orthopedics and Spine Businesses Global Leader with Extensive M&A Integration Expertise and Commercial and Operating Experience Across Key Orthofix Geographies Orthofix Medi...

2023-11-08 21:49:11 ET Orthofix Medical Inc. (OFIX) Q3 2023 Earnings Call Transcript November 08, 2023, 04:30 PM ET Company Participants Louisa Smith - IR, Gilmartin Group Cathy Burzik - Board of Directors Chair and Interim CEO Geoff Gillespie - Interim CFO ...

2023-11-08 17:40:44 ET More on Orthofix Orthofix: SeaSpine Transaction Not Pulling Its Economic Weight, Reiterate Hold Orthofix Medical cut to Hold at Stifel after C-suite changes Orthofix shuffles management, plans search for successors Seeking Alpha’...

In November 2023, entered into a new four-year financing agreement with borrowing capacity of up to $150 million Net sales of $184.0 million, an increase of 61% on a reported basis and an increase of 8% on a pro forma basis when normalizing for a one-time stocking order that occurred ...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

Orthofix Medical Inc. (OFIX) is expected to report $-0.75 for Q3 2023